Cart
sales@molnova.com
(E)-Elafibranor
CAS No. 575474-82-7
(E)-Elafibranor( R112 | R112 | R 112 )
Catalog No. M17545 CAS No. 575474-82-7
R112 is an ATP-competitive inhibitor of Syk kinase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 80 | In Stock |
|
| 2MG | 45 | In Stock |
|
| 5MG | 72 | In Stock |
|
| 10MG | 120 | In Stock |
|
| 25MG | 219 | In Stock |
|
| 50MG | 322 | In Stock |
|
| 100MG | 477 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1004 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(E)-Elafibranor
-
NoteResearch use only, not for human use.
-
Brief DescriptionR112 is an ATP-competitive inhibitor of Syk kinase.
-
DescriptionR112 is a Syk inhibitor. R112 inhibited degranulation induced by anti-IgE cross-linking in mast cells (tryptase release, effective concentration for 50% inhibition [EC(50)] = 353 nmol/L) or basophils (histamine release, EC(50) = 280 nmol/L), and by allergen (dust mite) in basophils (histamine release, EC(50) = 490 nmol/L). R112 also blocked leukotriene C4 production and all proinflammatory cytokines tested. Subsequent molecular characterization indicated that R112 is an ATP-competitive spleen tyrosine kinase (Syk) inhibitor (inhibitory constant [K(i)] = 96 nmol/L).(In Vitro):R112 (0.001-10 μM; 1 h) dose-dependently inhibits anti-IgE-mediated tryptase release and histamine release with EC50s of 0.353 and 0.28 μM, inhibits histamine release by basophils stimulated with an EC50 value of 0.49 μM, inhibits secretion of LTC4, TNF-α, GM-CSF and IL-8 with EC50s of 0.115, 2.01, 1.58 and 1.75 μM, respectively.R112 (0-10 μM; 40 min) inhibits Syk target LAT (Y191) phosphorylation.
-
In VitroR112 (0.001-10 μM; 1 h) dose-dependently inhibits anti-IgE-mediated tryptase release and histamine release with EC50s of 0.353 and 0.28 μM, inhibits histamine release by basophils stimulated with an EC50 value of 0.49 μM, inhibits secretion of LTC4, TNF-α, GM-CSF and IL-8 with EC50s of 0.115, 2.01, 1.58 and 1.75 μM, respectively.R112 (0-10 μM; 40 min) inhibits Syk target LAT (Y191) phosphorylation. Western Blot Analysis Cell Line:Human mast cells Concentration:0.4, 2 and 10 μM Incubation Time:40 min Result:Inhibited phosphorylation of the Syk target LAT (Y191) and also inhibited phosphorylation of Syk downstream events.
-
In Vivo——
-
SynonymsR112 | R112 | R 112
-
PathwayOthers
-
TargetOther Targets
-
RecptorSyk
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number575474-82-7
-
Formula Weight312.3
-
Molecular FormulaC16H13FN4O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 41 mg/mL; 131.28 mM
-
SMILESc1cc(cc(c1)O)Nc1nc(ncc1F)Nc1cc(ccc1)O
-
Chemical Name3,3'-((5-fluoropyrimidine-2,4-diyl)bis(azanediyl))diphenol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Sanguinarine
Sanguinarine is a specific inhibitor of Rac1b with anti-microbial, anti-oxidant and anti-inflammatory properties.
-
(R)-Omeprazole Sodiu...
(R)-Omeprazole (sodium) (Standard) is the analytical standard of (R)-Omeprazole (sodium). This product is intended for research and analytical applications. (R)-Omeprazole sodium is a gastric acid resistant compound with activity to inhibit gastric acid secretion. (R)-Omeprazole sodium is metabolized in vivo, and its metabolism is primarily affected by cytochrome P450 enzymes. The interaction between (R)-Omeprazole sodium and mannitol may affect its bioavailability in formulations. (R)-Omeprazole sodium exhibits reversible direct and metabolism-dependent inhibition of CYP2C19.
-
IMT1B
IMT1B is an orally active, noncompetitive and specific allosteric inhibitor of mitochondrial RNA polymerase (POLRMT) and inhibits mitochondrial DNA (mtDNA) expression. It has anti-tumour effects.
